Castle Biosciences Analyst Ratings
BenzingaMar 1 12:12 ET
Outperform Rating for Castle Biosciences Amid Strong Market Presence and Growth Prospects
TipRanksMar 1 01:01 ET
Analysts Conflicted on These Healthcare Names: Castle Biosciences (CSTL), DENTSPLY SIRONA (XRAY) and Silk Road Medical (SILK)
TipRanksFeb 29 09:00 ET
Analysts Conflicted on These Healthcare Names: Immunocore Holdings (IMCR), Voyager Therapeutics (VYGR) and Castle Biosciences (CSTL)
TipRanksFeb 29 08:02 ET
Buy Rating Affirmed for Castle Biosciences on Strong Performance and Positive Outlook
TipRanksJan 9 00:57 ET
Scotiabank Reaffirms Their Buy Rating on Castle Biosciences (CSTL)
TipRanksJan 8 07:18 ET
Castle Biosciences Analyst Ratings
BenzingaDec 14, 2023 06:37 ET
Scotiabank Sticks to Its Buy Rating for Castle Biosciences (CSTL)
TipRanksNov 6, 2023 08:26 ET
Castle Biosciences: Exceeding Forecasts and Dominating Skin Cancer Diagnostics Market – An Optimistic Buy Rating
TipRanksNov 6, 2023 01:07 ET
Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM), Castle Biosciences (CSTL) and Kura Oncology (KURA)
TipRanksNov 5, 2023 19:04 ET
Analysts Offer Insights on Healthcare Companies: Castle Biosciences (CSTL), Axonics Modulation Technologies (AXNX) and Apellis Pharmaceuticals (APLS)
TipRanksOct 9, 2023 01:20 ET
Analysts Offer Insights on Healthcare Companies: Castle Biosciences (CSTL), Lonza Group Ltd (Six Swiss: CH:LONN) and GN Store Nord (GB:0K9P)
TipRanksAug 14, 2023 05:02 ET
Keybanc Maintains Overweight on Castle Biosciences, Lowers Price Target to $25
BenzingaAug 4, 2023 04:32 ET
Castle Biosciences Analyst Ratings
BenzingaAug 4, 2023 04:31 ET
Analysts Are Bullish on These Healthcare Stocks: Insmed (INSM), Castle Biosciences (CSTL)
TipRanksAug 3, 2023 09:10 ET
BTIG Remains a Buy on Castle Biosciences (CSTL)
TipRanksJul 28, 2023 06:05 ET
SVB Securities Sticks to Their Buy Rating for Castle Biosciences (CSTL)
TipRanksJul 10, 2023 02:55 ET
BTIG Sticks to Its Buy Rating for Castle Biosciences (CSTL)
TipRanksJul 8, 2023 11:05 ET
Lake Street Reiterates Buy on Castle Biosciences, Maintains $32 Price Target
BenzingaJul 7, 2023 08:47 ET
Castle Biosciences (CSTL) Receives a Buy From SVB Securities
TipRanksJul 4, 2023 13:25 ET
No Data
No Data